These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Identification of an atypical CD8 T cell epitope encoded by murine cytomegalovirus ORF-M54 gaining dominance after deletion of the immunodominant antiviral CD8 T cell specificities. Holtappels R, Lemmermann NA, Thomas D, Renzaho A, Reddehase MJ. Med Microbiol Immunol; 2015 Jun; 204(3):317-26. PubMed ID: 25805564 [Abstract] [Full Text] [Related]
9. Highly protective in vivo function of cytomegalovirus IE1 epitope-specific memory CD8 T cells purified by T-cell receptor-based cell sorting. Pahl-Seibert MF, Juelch M, Podlech J, Thomas D, Deegen P, Reddehase MJ, Holtappels R. J Virol; 2005 May; 79(9):5400-13. PubMed ID: 15827154 [Abstract] [Full Text] [Related]
11. Predominant utilization of V beta 8+ T cell receptor genes in the H-2Ld-restricted cytotoxic T cell response against the immediate-early protein pp89 of the murine cytomegalovirus. Rodewald HR, Koszinowski UH, Eichmann K, Melchers I. J Immunol; 1989 Dec 15; 143(12):4238-43. PubMed ID: 2556481 [Abstract] [Full Text] [Related]
12. Phenotypic and functional characterization of CD8(+) T cell clones specific for a mouse cytomegalovirus epitope. Fernandez JA, Zavala F, Tsuji M. Virology; 1999 Mar 01; 255(1):40-9. PubMed ID: 10049820 [Abstract] [Full Text] [Related]
13. Peptides control the gain and loss of allele specificity by mutated MHC class I molecules. Hengel H, Burke K, Kyburz D, Zinkernagel RM, Koszinowski UH. J Immunol; 1995 May 01; 154(9):4557-64. PubMed ID: 7722309 [Abstract] [Full Text] [Related]
15. Development of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replication. Morello CS, Ye M, Spector DH. J Virol; 2002 May 01; 76(10):4822-35. PubMed ID: 11967299 [Abstract] [Full Text] [Related]
16. Assessment of antigenicity and genetic variation of glycoprotein B of murine cytomegalovirus. Xu J, Lyons PA, Carter MD, Booth TW, Davis-Poynter NJ, Shellam GR, Scalzo AA. J Gen Virol; 1996 Jan 01; 77 ( Pt 1)():49-59. PubMed ID: 8558128 [Abstract] [Full Text] [Related]
17. DNA immunization confers protection against murine cytomegalovirus infection. González Armas JC, Morello CS, Cranmer LD, Spector DH. J Virol; 1996 Nov 01; 70(11):7921-8. PubMed ID: 8892915 [Abstract] [Full Text] [Related]
18. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules. Hudrisier D, Oldstone MB, Gairin JE. Virology; 1997 Jul 21; 234(1):62-73. PubMed ID: 9234947 [Abstract] [Full Text] [Related]
20. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells. Rohrlich PS, Cardinaud S, Lulè J, Montero-Julian FA, Prodhomme V, Firat H, Davignon JL, Perret E, Monseaux S, Necker A, Michelson S, Lemonnier FA, Charneau P, Davrinche C. Hum Immunol; 2004 May 21; 65(5):514-22. PubMed ID: 15172452 [Abstract] [Full Text] [Related] Page: [Next] [New Search]